Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Transcutaneous Spinal Stimulation to Boost Exercise in Spinal Cord Injury

Official title: Transcutaneous Spinal Electrical Stimulation to Improve Exercise Function After Spinal Cord Injury.

Run by University of Manitoba · NCT07692191 · Data updated 2026-11-12

Researchers are testing whether a skin-friendly spinal stimulation method can help people with spinal cord injury exercise more effectively.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of Manitoba
Academic / other
Drugs / interventionscart
Locations1 site (Winnipeg, Manitoba)
StatusRecruiting
StartedJune 10, 2024
Main results expectedAugust 2026
Study endsOctober 2026
Registry record updatedJuly 9, 2026
Trial IDNCT07692191 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with traumatic or non-traumatic SCI, at least one year post-injury, with injury from C5 or lower, AIS A–D, who are medically stable and able to complete the exercise protocols.

Probably not a fit

Individuals with active cardiovascular disease, implanted cardiac devices, serious upper-extremity injuries, unaddressed cognitive impairment, or other listed exclusion criteria may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial tests the effect of transcutaneous spinal electrical stimulation (TSES) on acute exercise responses in adults with spinal cord injury. Participants perform incremental and steady-state exercise tests while metabolic and muscle responses are measured. The study compares responses within individuals and between those with tetraplegia and paraplegia, using a reference control group for context. Outcomes include metabolic energy use, muscle activity, and oxygen delivery to evaluate whether TSES enhances training potential and functional exercise capacity.

Why it matters

Potential benefit: If successful, TSES could improve how people with SCI respond to exercise, potentially aiding training adaptations and reducing sedentary-health risks.

How similar studies have gone: Prior case reports suggest TSES can increase peak exercise responses and time to fatigue during arm ergometry, but large randomized data in SCI are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* traumatic or non-traumatic spinal cord injury
* Spinal cord injury of at least one year duration, C5 or lower, AIS A - D
* medically stable and healthy enough to engage in and complete exercise requirements
* willing and able to complete the exercise protocols and testing requirements
* able to understand and follow written and verbal instructions from study staff
* able to communicate with study staff about their exercise capabilities and preferences

Exclusion Criteria:

* current serious injury (ies) of the upper extremities
* known cardiovascular disease
* unsatisfactory results of EKG screening
* implanted electronic cardiac devices (e.g., pacemaker, defibrillator, etc.)
* current pressure ulcer(s)
* morbid obesity
* known thyroid dysfunction
* current cancer
* current uncontrolled high blood pressure
* uncontrolled epilepsy
* current deep vein thrombosis
* ventilator dependency
* cognitive impairment

Where it's running

  • University of Manitoba
    Winnipeg, Manitoba, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.